Structural Heart Program

Structural heart disease refers to congenital or acquired defects in the heart's valves, wall, or chambers. Traditional open-heart surgery was previously the only option for addressing most of these problems. Now, we can offer minimally invasive or “percutaneous” options that can be equally or more effective at treating these conditions. Our multidisciplinary team specializes in minimally invasive treatments to replace damaged heart valves, as well as treating other common heart defects. We specialize in performing several of these advanced procedures such as:

• Transcatheter mitral valve repair (Mitraclip™)
• Left atrial appendage closure with the WATCHMAN FLX™

These minimally invasive therapies provide patients with an alternative to traditional open-heart surgery. In addition, our PFO closure program provides multidisciplinary evaluation and treatment options for patients with a history of unexplained, or cryptogenic, or stroke.

Conditions treated by the Structural Heart Program

• Aortic stenosis (TAVR)
• Atrial fibrillation and stroke risk (left atrial appendage closure)
• Mitral regurgitation (transcatheter mitral valve repair)
• Patent foramen ovale and atrial septal defect (PFO / ASD closure)

• Valvular heart disease

Structural Heart Team

Our structural heart team is made up of a multidisciplinary group of physicians and nurses who work closely together to develop a comprehensive treatment strategy. The team consists of experts in interventional cardiology, cardiac surgery, electrophysiology, and advanced cardiac imaging. We use specialized noninvasive testing to determine if a patient requires an intervention to repair or replace their heart valve. While open heart surgery can’t always be avoided, we try to use minimally invasive, catheter-based interventions whenever possible.